SEB Study Electronic Press Kit

SHARE

Press Release

Click here for the Study’s press release. 

Summary Report

Click here for a summary report of the Study.

About Ovarian Cancer

For information about ovarian cancer, including signs and symptoms, risk factors, and key stats, visit here.

For a Data Briefing about the latest projections on incidence and mortality through to 2050, click here.

Backgrounder

One of the primary objectives of this study is to bolster global advocacy efforts and assess the socioeconomic impact of ovarian cancer on patients, caregivers, health systems, and national economies.

Ovarian cancer is a worldwide concern, and much more needs to be done to address it comprehensively. If current trends continue, based on 2022 Globocan mortality rates, nearly eight million women are projected to die from ovarian cancer globally by 2050, with the heaviest burden falling on low- and middle-income countries where 70% of those diagnosed live.

Despite advances in innovative therapies, ovarian cancer remains one of the most lethal cancers. From 2022 to 2050, it is estimated that the disease will claim nearly eight million lives. Globocan’s 2022 projections indicate that by 2050, the annual number of women diagnosed with ovarian cancer will increase by over 55% to 503,448, while the number of annual deaths will rise by nearly 70% to 350,956.

Survival rates for ovarian cancer vary significantly across countries. In more developed nations, five-year survival rates currently range from 36% to 46%, but in some regions, the rates are much lower. Overall, survival rates for ovarian cancer are significantly lower than those for other cancers, such as breast cancer, where five-year survival rates in many countries approach 90%.

Q&A

Click here to read a Q&A for the study.

Infographics

Australia Infographic (in AUD)Kazakhstan Infographic (in USD)

Australia Infographic (in USD)Kenya Infographic (in USD)

Canada Infographic (in CAD)Malaysia Infographic (in USD)

Canada Infographic (in USD)Nigeria Infographic (in USD)

Colombia Infographic (in USD)UK Infographic (in GBP)

India Infographic (in Rupees)UK Infographic (in USD)

India Infographic (in USD)USA Infographic (in USD)

Malawi Infographic (in USD)

Patient Stories

Below, you’ll find videos showcasing patient stories from various countries involved in the Study. These personal accounts are part of our Inspiring Voices series, highlighting journeys of resilience and hope.

To explore more stories from the 11 participating countries, among others, visit the Inspiring Voices page on our website.

Bios

The corresponding author is Mikis Euripides, Study Lead.

Bio: Experienced Senior Director with a demonstrated history of working in the health sector. Experience of working in the pharmaceutical industry and patient groups at a senior level. Skilled in Nonprofit Organizations, Public Affairs, Corporate Social Responsibility, Crisis Communications, and Event Management. Strong business development professional with a Master of Science (MSc) focused in Global Politics from Birkbeck, University of London. You can find him on LinkedIn.

Media Contact

For further information and inquiries, contact Helen Shik at helen@worldovariancancercoalition.org or Annabel Deegan at media@worldovariancancercoalition.org.

SHARE